Riskpilot← Back to searchSign inGet full accessGC Finland Oy
OYActiveY-tunnus 3196095-2Lemminkäisenkatu 46Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20215 employees
Revenue 2025
EUR 1,3M
+3% vs 2024
EBITDA margin
4.4%
+4% vs 2024
Equity ratio
27.6%
Financial strength
Net profit 2025
EUR 44K
+3% vs 2024
| Revenue | EUR 1,3M | +3% |
| EBITDA | EUR 56K | +4% |
| Net profit | EUR 44K | +3% |
| Total assets | EUR 353K | +56% |
| Equity | EUR 97K | +31% |
| Employees | 5 | — |
Legal name
GC Finland Oy
Y-tunnus number
3196095-2
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. maaliskuuta 2021
Share capital
EUR 0
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on hammastuotteiden ja -instrumenttien, näitä koskevien materiaalien, kauneudenhoitoaineiden, hammaslääketieteellisten ja kvasilääketieteellisten hammastuotteiden ja suunhoitotuotteiden myynnin edistäminen ja markkinointi.
Address
Lemminkäisenkatu 46
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 822 | 1 025 | 1 240 | 1 282 |
| Staff expenses | −478 | −611 | −157 | −781 |
| EBITDA | 37 | 45 | 54 | 56 |
| Depreciation & amort. | — | −0 | −0 | −0 |
| EBIT | 37 | 45 | 54 | 56 |
| Net financials | −1 | −0 | −0 | −1 |
| Profit before tax | 35 | 44 | 53 | 55 |
| Tax | 7 | 9 | 11 | 11 |
| Net profit | 28 | 35 | 43 | 44 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 163 | 279 | 227 | 353 |
| Equity | 28 | 49 | 75 | 97 |
| Long-term debt | 19 | 0 | 0 | 0 |
| Short-term debt | 116 | 229 | 153 | 256 |
| Total debt | 135 | 229 | 153 | 256 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20222025
Equity ratio
27.6%
This company
38.2%
Market median
-28% vs market
20222025
Return on equity
45.4%
This company
18.4%
Market median
+147% vs market
20222025
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20222025
Asset turnover
3.63×
This company
1.12×
Market median
+224% vs market
20222025
Debt / equity
2.63×
This company
0.62×
Market median
-324% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-03-01 – 2022-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (2) | ||
SK Deputy Member | Deputy Member | 2021 – 2021 |
EJ Audit | Audit | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairperson | 2021 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GC Finland Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sini Krista Siro | Deputy Member | 0 companies |
| Esa Jaakko Kailiala | Audit | 0 companies |
| Jyrki Olavi Kurokallio | Chief Executive Officer | 0 companies |
| Frank Michael Rosenbaum | Board of Directors | 0 companies |
| Katrin Langer | Board of Directors | 0 companies |
| Josef Richter | Chairperson | 0 companies |
| Dries Julia W. Baets | Board of Directors | 0 companies |
| Jarkko Ilari Ruohola | Board of Directors | 0 companies |